Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids
Tools
Tools
Tools
Brackenridge, AL, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, AM and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids DIABETIC MEDICINE, 26 (5). 532 - 539. ISSN 0742-3071
![[img]](/style/images/fileicons/application_pdf.png)
| PDF (licence) 32Kb | |
| PDF Available under License : See the attached licence file. 135Kb |
Official URL: http://dx.doi.org/10.1111/j.1464-5491.2009.02729.x
| Item Type: | Article |
|---|---|
| Additional Information: | The definitive version is available at www.blackwell-synergy.com |
| Uncontrolled Keywords: | Science & Technology, Life Sciences & Biomedicine, Endocrinology & Metabolism, intermediate density lipoprotein, low-density lipoprotein, non-esterified fatty acid, peroxisome proliferators-activated receptor-gamma agonist, Type 2 diabetes, very low-density lipoprotein, IMPROVES GLYCEMIC CONTROL, LOW-DENSITY LIPOPROTEIN, INSULIN-RESISTANCE, APOLIPOPROTEIN-B, CONTROLLED-TRIAL, THERAPY, MELLITUS, DYSLIPIDEMIA, COMBINATION, THIAZOLIDINEDIONES |
| Divisions: | Faculty of Health and Medical Sciences > Nutrition and Metabolism |
| Related URLs: | |
| ID Code: | 711084 |
| Deposited By: | Symplectic Elements |
| Deposited On: | 07 Aug 2012 14:27 |
| Last Modified: | 02 Mar 2013 14:41 |
Document Downloads
Repository Staff Only: item control page